CHAPTER  2 REFERENCES & SELECTED BIBLIOGRAPHY

1. Adams, R. Marihuana. Harvey Lect., 1942, 37, 168-197.
2. Addiction Research Foundation of Ontario. Marihuana and its effects: An assessment of current knowledge. Toronto: ARF, 1968.
3. Addiction Research Foundation of Ontario. Facts about solvents. Toronto: -ARF, 1969.
4. Addiction Research Foundation of Ontario. Preliminary brief submitted to the Commission of Inquiry Into the Non-Medical Use of Drugs, December, 1969.
5. Advisory Committee on Drug Dependence. Cannabis. London: Her - . Majesty's Stationery Office, 1968. (The "Wootton Report").
6. Allen, J. R., and West, L. J. Flight from violence; Hippies and the green rebellion. Amer. J. Psychiat., 1968, 125, 364-370.
7. Allentuck, S., and Bowman, K. M. The psychiatric aspects of marihuana intoxication. Amer. J. Psychiat., 1942, 99, 248-251.
8. American Medical Assdti tion Committee on Alcoholism and Addiction. Dependence on barbiturates and other sedative drugs. J.A.M.A., 1965, 193, 673-677.
9. American Medical Association. Dependence on cannabis (marihuana). J.A.M.A., 1967, 201, 368-371.
10. American Medical Association. Marihuana thing. JA.M.A., 1968, 204-. 1187-1188.
11. Ames, F. A clinical and metabolic study of acute intoxication with cannabis sativa and its role in the model psychoses. J. Ment. Sci., 1958, 104, 972-999.
12. Andrews, G., and Vinkenoog, S. (Eds.). The book of grass: An anthology ôf Indian Hemp. New York: Grove Press, 1967.
13. Anslinger, H. J., and Cooper, C. R. Marijuana, assassin of youth. American Magazine, 1937, 124, 19-20; 150-153.
14. Arnold, D. O. The meaning of the LaGuardia Report. In J. L. Simmons (Ed.), Marihuana: Myths and realities. North Hollywood, California: Brandon House, 1967.
15 Attack on Narcotic Addiction and Drug Abuse, 1969, 3 (3), 3-. N.Y. State Narcotic Addict. Control Commission.
16. Ausubel, D. P. Drug addiction: Physiological, psychological, and sociological aspects. New York,. Random House, 1958.
17. Bakewell, W. E., Jr., and Wikler, A. Non-narcotic addiction: Incidence in a university hospital psychiatric ward. J.A.M.A., 1966, 196, 710-713.
18. Banay, R. S. Alcoholism and crime. Quart. J. Stud. Alcoh., 1942, 2, 686-716. F;
19. Becker, H. S. Becoming a marihuana user. Am. J. Sociol., 1953, 59, 235-242.
20. Becker, H. S. Marihuana use and social control. Soc. Prob., 1955, 3, 35-44.
21. Becker, H. S. 'History, culture and subjective experience: An exploration of the social bases of drug-induced experiences. J. Health Soc. Behay., 1967, 8, 163-176.
22. Beecher, H. K. Quantitative effects of drugs: -Measurement of subjective f,.    responses. New York: Oxford University Press, 1959.
23. Bell, D. S. Addiction, to stimulants. Med. J. Austral., 1967, Jan. 14, 41-451 R,

24. Benabud, A. Psycho-Pathological -aspects of the cannabis situation in Morocco: Statistical data for 1946. Bull. Narc., 1957, 9, 1-16.

25 Bloomquïst, E Marijuam Beverly Hills: Glencoe Press, 1968.
26 Blum, R. H., and Associates. Uli'npiates: Use and user., of LSD. New York: Atherton Press, 1964.
27 Blum, R. H. Mind altering drugs and dangerous behavior: Dangerous drugs. Appendix A-1. Task Force Report: Narcotics and drug abuse. Washington, D.C.: U.S. Government Printing Office, 1967 (a).
28 Blum, R. H. Mind altering drugs and dangerous behavior: Narcotics. Appendix A-2. Task Force Report: Narcotics and drug abuse. Washington, D.C.: U.S. Government Printing Office, 1967 (b).
29. Blum, R. H. and Associates. Society and drugs. Vol. I. San Francisco: Jossey-Bass Inc., 1969.
30. Bouquet, J. Cannabis. Bull. Narc., 1951, 3, 22-45.
31. Boyce, S. S. Hemp (Cannabis saliva). A practical treatise on the culture of hemp for seed and fiber with a sketch of the history and nature of the plant. New York: Orange Judd, 1912. Quoted by O. J. Kalant (1968).
32. Bracken, J. (Chm.). Report of the Manitob i Liquor Enquiry Commission. Winnipeg, 1955.
33. Brill, H. The case against marijuana. J. Sch. Health, 1968, 38, 522-523.
34. Brill, H., and Hirose, T. The rise and fall of a methamphetamine epidemic: Japan 1945-55. Seminars in Psychiatry, 1969, 1, 179-194.
35. Bromberg, W. Marihuana intoxication: A clinical study of cannabis sativa intoxication. Amer. J. Psychiat., 1934, 91, 303-330.
36. Caldwell, D. F., Myers, S. A., and Domino, E. F. Effects of marihuana smoking on sensory thresholds in man. In D. H. Efron (Ed.), Psychotomimetic drugs. New York: Raven Press, 1969.
37 Campbell, E. O'F. Alcohol involvement in fatal motor vehicle accidents. Mod. Med., 1969, 24, 35-42.
38 Carey, J. T. The college drug scene. Englewood Cliffs, N.J.: Prentice-Hall, 1968.
39 Carpenter, J. A. Effects of alcohol Quart. J. Stud. Alcoh., 1962, 23, 274-3
40. Chap,  P. A. L. Cannabis—a toxic of eighty takers. Brit. J. Addict., 1966,
41. Cheek, F. E., Newell, S., and Sarett, M. The down-head behind an uphead—the heroin addict takes LSD. Int. J. Addict., 1969, 4, 101-119.
42. Chein, I., Gerard, D. L., Lee, R. S., Rosenfeld, E., and Wilner, D. M. The road to H. New York: Basic Books, 1964.
43. Cherubini C.. E. A review of the medical complications of narcotic addiction. Int. J. Addict., 1968, 3, 163-175.
44. Chopra, G. S. Man and marijuana. Int. J. Addict., 1969, 4, 215-247.
45. Chopra, R. N. and Chopra, G. S. The present position of hemp drug addiction in India. Indian Medical Research Memoirs, 1939, No. 31, 1-119.
46. Clark, D. C., and Nakashima, E. N. Experimental studies of marihuana. Amer. J. Psychiat., 1968, 125, 379-384.
47. Clement, W. R., Solursh, L. P., and Van Ast, W. Abuse of amphetamine and amphetamine-like drugs. In press, 1970.
48. Cohen, M., Marinello, M., and Bach, N. Chromosomal damage in human leukocytes by lysergic acid diethylamide, Science, 1967, 155, 1417-1419.
49., Cohen, S. Lysergic add'    - laznide: Side effects and ooMl catiogs."J Nerv. Ment. Dis., 1060,130, 30-40.
50. Cohen, S., and Ditman, K. S. Complications associated with lysergic acid diethylamide (LSD-25). J.A.M.A., 1962, 189, 181-182.
51. Cohen, S., and Ditman, K._ S. Prolonged adverse reactions to lysergic acid diethylamide. Arch. Gen. Psychiat., 1963, 8, 475-480.
52. Cohen, P. J., and Dripps, R. D. History and theories -Of general anesthesia. In L. S. Goodman and A. Gilman, The pharmacological basis of therapeutics. (3rd ed.) New York: MacMillan, 1965.
53. Cole, J. O., Peeking through the double blind. In D. H. Efron (Ed.), Psychopharmacology: A review of progress 1957-1967. Washington, D.C.: U.S. Government Printing Office, 1968.
54. Commonwealth of Massachusetts. Supreme Judicial Court for the Commonwealth. Suffolk County. December Sitting, 1968, No. 14, 113. Comthon- wealth v. Joseph D. Leis. Commonwealth v. Ivan Weiss.
55. Connell, K. H. Ether drinking in Ulster. Quart. J. Stud. Alcoh., 1965, 26, 629-653.
56. Connell, P. H. Amphetamine psychosis. London: Chapman and Hall, 1958.
57. Conger, J. J. Reinforcement theory and the dynamics of alcoholism. Quart. J. Stud. Alcoh., 1956, 17, 296-305.
58. Corey, M. J., Andrews, J. C., McLeod, M. J., MacLean, J. R., and Wilby, W. E. Chromosome studies on patients (in vivo) and, cells (in vitro) treated with lysergic acid diethylamide. Paper presented at a meeting of the Commission of Inquiry into the Non-Medical Use of Drugs, Halifax, Jan. 1970. (Also in press, 1970).
59. Council on Mental Health. Marihuana and society. J.A.M.A., 1968, 204, 91-92.
60. Cox,-C., and Smart, R. G. The nature and extent of speed use in North America. Addiction Research Foundation of Ontario, Substudy 1-32 and 7-69, 1969.
61. Crancer, A., Jr., Dille, J. M., Delay, J. C., Wallace, J. E., and Haykin, M. D. Comparison of the effects of marihuana and alcohol on simulated driving performance. Science, 1969, 164, 851-854.
62. Cumberlidge, M. C. The abuse of barbiturates by heroin addicts. Canad. Med. Ass. J., 1968, 98, 1045-1049.
63. Davidson, R. H., and Barclay, J. F. A rational analysis of the legal status of marihuana with jurisprudential considerations. Brief submitted to the Commission of Inquiry into the Non-Medical Use of Drugs, February, 1970.
64. Davis, M. A. Antidepressants, stimulants, hallucinogens. In Annual Reports in Medicinal Chemistry, 1967.
65. Denson, R. Complications of therapy with lysergide. Canad. Med. Ass. J., 1969, 101, 53-57.
66. De Ropp, R. S. Drugs and the mind. New York: Grove Press, 1957.
67. DiPalma, J. R., (Ed.), Drill's pharmacology in medicine. (3rd "ed.) New York: McGraw-Hill, 1965.
68. Domino, E. F. Psychosedative drugs II Meprobamate, chlordiazepoxide and miscellaneous agents. In J. R. DiPalma (Ed.), Drill's pharmacology in medicine. (3rd ed.) New York: McGraw-Hill, 1965.
69  Eddy, Halbach, Isbell, Seevers WHO 1965 Bulletin World Health Organization, 1965, 32, 721-733.
70. Efron, D. H. (Ed.) Psychopharmacology: A ret4ew of progress, 1957-1967. Washington, D.C.: U.S. Government Printing Office, 1968.
71. Ellinwood, E. H. Amphetamine psychosis: 1. Description of the individuals and process. J. Ner. Ment. Dis., 1967, 133, 273-283.
72. Essig, C. F. Addiction to barbiturate and nonbarbiturate sedative drugs. In A. Wikler (Ed.), The addictive states. Proceedings of the Association for Research in Nervous and Mental Disease, Vol. XLVI. Baltimore: Williams & Wilkins, 1968.
73. Evans-Wentz, W. Y. (Ed.) The Tibetan book of the dead. N ew York: Oxford :7, University Press, 1960.
74. Farmilo, C. G., Davis, T. W. M., Vandenheuvel, F. A., & Lane, R. Studies on the chemical analysis of marihuana. Proc. Canad. Soc. Forensic Sci., 1962, 1, 1-50.
75. Farnsworth, D. L., & Oliver, H. K., The drug problem among young--:' people. Rhode Island Med. J., 1968, 51, 179-182.
76, Fattah, E. A.'Pour de nouvelles mesures legislatives sur les drogues et la toxicomanie. Toxicomanies, 1969, 2, 85-108.
77. Finlator, J. Drug abuse control F.B.F. Law Enfor. Bull., 1967, 6, 1-5.
78  Finlator, J. The Playboy Panel: The drug revolution. Playboy, 1970, t    17 (2), 53-.
79. Food and Drug Directorate, Department of National Health and Welfare, 1969. (Personal communication).
80. Forney, R. B., & Harger, R. N. The alcohols. In J. R. DiPalma (Ed.) Drill's pharmacology in medicine. (3rd ed.) New York: McGraw-Hill, 196..
81. Fort, J. The AMA lies about pot. Ramparts, 1968, 7, (August), 12-13. 82.` Fort, J. Pot: A rational approach. Playboy, 1969, 17 (10), 131-.
83. Franks, C. M. Alcohol, alcoholism and conditioning: A review of the literature and some theoretical considerations. J. Ment. Sci., 1958, 104, 14-33.
84. Gainage, 3. R., & Zerkin, E. L. A comprehensive guide to the english= ., language literature on cannabis (marihuana). Wisconsin: Stash Press, 1969. 4,
85. Geber, W. F.,- Schramm, L. C. Effect of marihuana extract on fetat-_ hamsters and rabbits. Toxic. Appl. Pharmacol., 1969, 14, 276-282.
86. Gellman, V. Glue-snif ng among Winnipeg school children. Canad, Med. Ass. J., 1968, 98, 411-413.
87. Ginsberg, A. The great marihuana hoax: First manifesto to end the bring=' down. Atlantic Monthly, 1966, 28 (November), 107-113.
88. Glaser, D., Inciardi, J. T., & Babst, D. Later heroin use by marijuana-using, heroin-using and non-drug-using adolescent offenders in New York City. Int. J. Addict., 1969, 4, 145-155.
89.'Glatt, M. M. The abuse of barbiturates in the United Kingdom. Bull. Narc., 1962, 14, 19-38:
90. Goode, E. Marijuana and the politics of reality. J. Health Soc. Behan.; 1969, 10, 83-94.
91. Goode, E. Multiple drug use among marijuana smokers. Soc. Prob., 1969, 17, 48-64.
92 Goode The marijuana market, 1969
93. Goode, E. The marijuana smokers. In press, 1970.
94. Goodman, L. S, & Gilman, A. The pharmacological basis of therapeutic i •(3rd ed.) New York: MacMillan, 1965.
95. Grinspoon, L. Marihuana. Sd. Amer., 1969, 221 (6), 17-25.
96. Grossman, W. Adverse reactions associated with cannabis products in India. Ann. Intern. Med., 1969, 70, 529-533.
97. Haas, H., Fink, H., & Kiln, B. M. The placebo problem. Psychopha cology Service Center Buhetin, 1963; 2, (8) 1-65 (Translation).
98. Halliday, R. Barbiturate abuse: An iatrogenic disorder? B. C. Med. J. 1967, 9, 374-378.
99. Hecht, F., Beals, R. K., Lees, M. H., 'Jolly, H., & Roberts, P. Lysergicacid-diethylamide and cannabis as possible teratogens in man. The Lancet, 1968, November, 1087-.
100. Hekimian, L. J., & Gershon, S. Characteristics of drug abusers admitted to a psychiatric hospital. J.A.M.A., 1968, 205, 124-130.
101. Hoffer, A. LSD: A review of its present status. Clin. Pharm. R Ther., 190, 6, 183-225.    -    -
102. Hofmann, A. Psychotomimetic drugs: Chemical and pharmacological aspects. Acta Physiologica et Pharmacologica Neerlandica, 1959, 8, 240-.258.
103. Hofmann, A. The active principles of the seeds of rives corymbosa and impomoea violacea. Bot. Mus. Leaflets, 1963, 20 (6), 194-212.
104. Hollister, L. E., & Gillespie, H. K. Similarities and differences between the effects of lysergic acid diethylamide and tetrahydrocannabinol in man. Paper presented at the Rutgers Symposium on Drug Abuse, Rutgers-New Brunswick, New Jersey, June, 3-5, 1968.
105. Houston, B. K. Brief communications—review of the evidence and qualifications regarding the effects of hallucinogenic drugs on chromosomes and embryos. Amer. J. Psychiat., 1969, 126 251-253.
106. Huxley, A. The doors of perception and heaven and hell. Harmondsworth: Penguin, 1959.
107: Indian Hemp Drugs Commission Report. Simla, India: Government Central Printing Office, 1894. 7 vols.
108. Isbell, H., Fraser, H. F., Wikier, A., Belleville, R. E., & Eisen/non, A. J. An experimental study of the etiology of "rum fits" and delirium tremens. Quart. J. Stud. Alcoh., 1955, 16, 1-.
109. Isbell, H., Gorodetzsky, C. W., Jasinski, D., Claussen, U., Spulak, F. V.,. & Korte, K. Effects (-)-delta-9- of trans-tetrahydrocannabinol in Man. Psychopharmacologia, 1967, 11, 184-188.
110. Jaffe, J. H. Narcotic analgesics. In L. S. Goodman & A. Gilman, The pharmacological basis of therapeutics. (3rd ed.) New York: MacMillan, 1965. (a)
111. Jaffe, J. H. Drug addiction and drug abuse. In L. S. Goodman. and A. Gilman, The pharmacological basis of therapeutics. (3rd ed:) New York: MacMillan, 1965. (b)    • l F
112. Jellinek, E. M. The disease concept of alcoholism. Ne* Haven: Hillhouse Press, 1960.
113. Jellinek, E. M. The symbolism of drinking: A ciilture-historical approach. Toronto: Addiction Research Foundation of Ontario, Substudy 3-2 & Y-65.
114  Jellinekt, E M., & McFarland, R.: A. Analysis of psychological experimentson the effects of alcohol. Quart. J. Stud. Alcoh., 1940, 1, 272-371.
115. Johnson, R. D. Medico-social aspects of marijuana. Rhode Island Med. .1.,1968, 51, 171-178.
116. Jones, R. T. & Stone, G. C. Psychological studies of marijuana and alcohol in man. Paper presented at the 125th annual meeting of the American Psychiatric Association, Bal Harbour, Florida, May 1969.
117. Joyce, C. R. B. (Ed.) Psychopharmacology: Dimensions and perspective. London: Tavistock Publications, 1968.
118. Kalant, H. Marihuana and simulated driving. Science, 1969, 166, 640.
119. Kalant, O. J. The amphetamines: Toxicity and addiction: Brookside Mono-, graph No. 5. Toronto: University of Toronto Press, 1966.
120. Kalant, O. J. An interim guide to the cannabis (marihuana) literature. Addiction Research Foundation Bibl. Series No. 2, 1968.
121. Kaplan, J. (Ed.) Marijuana. Report of the Indian Hemp Drugs Commission 1893-1894. Silver Spring, Maryland: Jefferson; 1969.
122.` Kato, T., & Jarvik, L. F. LSD and genetic damage. Dis. Nerv. Syst., 1969, 30, 43-46.
123. Keeler, M. H. Adverse reactions to marihuana. Amer. J. Psychiat., 1967, 124, 128-131.
124. Kramer, J. C., Fischman, V S , & Littlefield, D. C. Amphetamine abuse: Pattern and effects of high doses taken intravenously. J.A.M.A., 1967, 201, 89-93.
125. Kupperstein, L. R., & Susman, R. M. Bibliography on the inhalation of glue fumes and other toxic vapors—a substanre abuse practice among adolescents. Int. J, Addict., 1968, 3, 177-197.
126. Lasagna, L., von Felsinger, J. M., & Beecher, H. K. Drug-induced mood changes in man. I: Observations on healthy subjects, chronically ill patients, and 'postaddicts'. J.A.M.A., 1955, 157, 1006-1020.
127. Laurie, P. Drugs: Medical, psychological and social facts. Harmondsworth: Penguin, 1967.
128. Leary, T., Metzner, R., & Alpert, R. The psychedelic experience. New Hyde Park, N.Y.: University Books, 1964.
129. Leary, T., Metzner, R., Presnell, M., Weil, G., Schwitzgebel, R., Kinne, S. A change program for adult offenders using psilocybin. Psychotherapy, 1965, 2. See also Leary, T., &-Clark, W. H. Religious imp'lichtions of consciousness-expanding drugs. Relig. Ed., 1963, 1, 251-256.
130.. Lehmann, H. E. Phenomenology and pathology of addiction. Compreh. Psychiat., 1963, 4, 168-180.
131. Lehmann, H. E., & Ban, T. A. Pharmacotherapy of tension and anxiety. In press, 1970.
132. 'Levine, J. & Ludwig, A. The LSD controversy. Compreh. Psychiat., 1964, 5, 314-321.
133. Levy; B., & Ahlquist, R. P. Adrenergic drugs. In J. R. DiPalma (Ed.), Drill's pharmacology in medicine. (3rd ed.) New York: McGraw-Hill, 1965.
134. Lewis, A. Cannabis. Appendix 1. In Advisory Committee on Drug Dependence, Cannabis. London: Her Majesty's Stationery Office, 1968.
135. Lindesmith, A. R. The addict and the law. New York: Random House, 1965.
136. Litt, I. F., & Cohen, M. I. Danger ... vapor harmful: Spot-remover sniffing. New Eng. J. Med., 1969, 281, 543-544.
137. Louria, D. B. The dr4 scene. ew York: McGraw-Hill, 1958.
138. Ludwig, A. M., & Levine, J. The clinical efl'eèts of psychedelic agents. Clin. Med., 1966, 73, 22-.
139. Lynch, V. D. Marihuana Research—a perspective. Paper presented at the Tenth Annual Conference, International. Narcotic Enforcement Officers' Association, Philadelphia, Sept. 18, 1969.
140. Malcolm, A. I. On solvent sniffing. Toronto: Addiction Research Foundation of Ontario, 1969.
141. Manheimer, D. I., & Mellinger, G. D. Marijuana use among urban adults. Science, 1969, 166, 154.4-1545.
142. Margolis, J. S. & Clorfene, R. A child's garden of grass. North Hollywood: Contact Books, 1969.
143. Marshman, J. A further note on the composition of illicit drugs. 1970. Unpublished paper.
144. Marshman, J. A., & Gibbins, R. J. The credibility gap in the illicit drug market. Addictions, 1969, 16 (1), 22-25.
145. Martin, W. R., & Jasinski, D. R. Physiological parameters of morphine dependence in man: Tolerance, early abstinence, protracted abstinence. J. Psychiat. Res., 1969, 7, 9-17.
146. , Masserman, J. H., and Yum, K. S. An analysis of the influence of alcohol on experimental neurosis in cats. Psychosom. Med., 1946, 8, 36-52.
147. Masters, R. E. L., & Houston, J. The varieties of psychedelic experience. New York: Dell, 1966.
148. Maynert, E. W. Sedatives and hypnotics II. Barbiturates. In J. R. DiPalma (Ed.), Drill's pharmacology in medicine. (3rd ed.) New York: McGraw-Hill, 1965.
149. Mayor's Committee on Marihuana. The marihuana problem in the City of New York: Sociological, medical, psychological and pharmacological studies. Lancaster, Penn.: Jacques Cattell Press, 1944. ("The La-Guardia Report").
150. McGlothlin, W. H. Toward a rational view of marihuana. In J. L. Simmons (Ed.), Marihuana: Myths and realities. North Hollywood: Brandon House, 1967.
151. McGlothlin, W. H. Cohen, S., & McGlothlin, M. S. Long lasting effects of LSD on normals. Arch. Gen. Psychiat., 1967, 17, 521-532.
152. McGlothlin, W. H., Arnold, D. O., & Freedman, D. X. Organicity measures following repeated LSD ingestion. Arch. Gen. Psychiat., 1969, 21, 704-709.
153. McGlothlin, W. H., Arnold, D. O., & Rowan, P. K. Marijuana use among adults. Psychiatry, 1970, lit press.    -
154. McGlothlin, W. H., & West, L. J. The marihuana problem: An overview. Amer. J. Psychlat., 1968, 125, 370-378.
155. Mechoulam, R., & Gaoni, Y. Recent advances in the chemistry of hashish. Fortschr. Chem. Organ. Naturst., 1967, 25, 175-213
156. Mendelson, J. H. Experimentally induced chronic intoxication and withdrawal in alcoholics. Quart J. Stud. Alcoh., 1964, 25, suppl. No. 2.
157. Meyer, R. E. Adverse reactions to hallucinogenic drugs with backgraiod. papers. Washington: U,S. Public Health Services Publication No: 1810,_ 1969.
158. Mikuriya, T. H. Physical, mental, and moral effects of marijuana: The Indian Hemp Drugs Commission Report. Int. J. Addict., 1968, 3, 253-270.
159 Mikuriya, Marijuana in Medicine, 1969
160.Miller D. E: Narcotic drug and marihuana controls. Paper' presented at National Association-of Student Personnel Administrators Drug Education Conference, Washington, D.C., Nov. 7-8, 1966.
161. Miller, R. D. Some principles of psychopharmacology: Implications for -1, the social control of drug abuse. Paper presented at the Sir George Williams Symposium on DrugAbuse, Montreal, February, 1969.
162. Milman, D,. H. The role of marihuana in patterns of drug abuse by adolescents. J. Pediat.,.1969, 74, 283-290.
163. Miras, C. J. Experience with chronic hashish smokers. In J. R. Wittenborg (Ed.) Drugs and youth. Springfield, Ill.: Charles C. Thomas, 1969.'
164. Modell, W. Mass drug catastrophes and the roles of science and technology. Science, 1967, 1.56, 346-351.
165 Moore„ L. A.,, Jr. Marijuana (Cannabis) bibliography, .1960-1968. Los Angeles, Cal.: Bruin Humanist Forum, 1969.
166. Murphy, H. B. M. The, cannabis habit: A review of recent psychiatric literature. Bull. Narc., 1963, 15, 15-23.
167 Murray, N. Covert effects of chlordiazepoxide therapy. J. Neuropsychiat., 1962, ,Ç168-170.
168. Nagle, D. R. Anesthetic addiction and drunkenness: A contemporary and historical survey. Int. J. Addict., 1968, 3, 25-39r
169. Narcotic Addiction Foundation of B.C. Glue sniffing.  Vancouver: N.A.F. of B.C., 1968.
170a. Narcotic Addiction Foundation of B.C. Brief submitted to the Commission of Inquiry into the Non-Medical Use of Drugs, 1969.
170b. New York Times. January 13, p. 13 and January 19, p. 22, 1968.
171. Nowlis, H. H. Communicating about drugs. Paper presented at National Association of Student Personnel Administrators Drug Education Conference, Washipgton, D.C., Nov. 7-8, 1966.
172. Nowlis, H. H. Drugs on the college campus. Garden City, N.Y.: Doubleday, 1969.    —    -
173. Oki, G. Personal communication. 1970.
174, Osmond, H. A review of the clinical effects of psychotomimetic agents. Ann. N.Y. Acad. Sci., 1957, March 14. Reprinted in D. Solomon (Ed.) op... cit., 1964.
175. Pahnke, W. N. Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness. (Doctoral dissertation, Harvard University) Canibridge, Massachusetts, 1963. Also discussed in W. Pahnke, & W. Richards, op. cit. 1966.
176. Pahnke, W. N. The mystical and/or religious element in the psychedelic experience. Paper presented to the third annual conference of the R. M. Bucke Memorial Society for the Study of Religious Experience, Oct. 13-15, 1967.
177 Pahnke, W. N., & Richards, W. A. Implications of LSD and experimental mysticism. J Relig. Health, 1966, 5, 175-208. __
178. Parry, H. J. Use of psychotropic-drugs by U.S. adults. Pub. Health Rep., 1968, 83, 799-810.
179. Perna, D. Psychotogenie effect of marihuana. J.A.M.A., 1969, 209, 10851086.
180 Peterson Psychophramacology psÿchology: A Setftisel6ttIol1 textbook Iowa: Brown Co., 1966.
181. Playboy Panel: The drug revolution. Playboy, 1970,17 (2), 53-.
182. Popham, R. E. (Ed.) Alcohol and alcoholism. Toronto: University of Toronto Press, 1970.
183. Popham, R. E., & Schmidt, W. The prevention of alcohol problems: Ecological studies of the effects of government control measures. Addiction,• Research Foundation of Ontario, Toronto. Mimeo, n.d.
184. Rawlin, J. Street level abuse of amphetamines. In J. Russo (Ed.), Amphetamine abuse. Springfield, Illinois: Charles C. Thomas, 1968.
185. Richards, L. G., Joffe, M. H., Smith, J. P., & Spratto, G. R. LSD-23:• A factual account. Washington, D.C.: U.S. Department of Justice, Bureau ;„ of Narcotics and Dangerous Drugs, 1969.
-186. Ritchie, J. M. The aliphatic alcohols. In L. S. Goodman & A. Gilman, The pharmacological basis of therapeutics. (3rd ed.) New York: MacMillan, 1965.
187. Robins, L. N., Dervish, H. S., & Murphy, G. E. The long-term outcome for adolescent drug users. A follow-up study of 76 users and 146 non-users.; Paper presented at the American Psychopathological Association's Symposium, "Psychopathology of Adolescence", New York City, February, 1969. •'_
188. Roffman, R. A., & Sapol, E. Marijuana in Vietnam: A survey of use among army enlisted men in the two southern corps. Technical Report for the Surgeon-General. Department of the /Army, 1969.
189. Rosenthal, S. H. Persistent halluelnosis following repeated administration of hallucinogenic drugs. Amer. J. Psychiat., 1964, 121, 238-244.
190. Rosser, W. W. A survey of barbiturate tranquilizer and amphetamine usage. Canad. Fam. Physic., 1969, 15 (7), 39-41.
191. Rowell, E. A., & Rowell, R. On the trail of marihuana, the weed of madness, Mountain View, California: Pacific Press, 1939. Quoted in A. R. Linde• smith op. cit.
192. Rutman, L (Ed.), Drugs: Use and abuse. Winnipeg: University of Winnipeg Press, 1969.
193. Savage, C., & Stolaroff, M. J. Clarifying the confusion regarding ISD-25. J. Nerv. Ment. Dis., 1965, 140, 218-221.
194. Schwarz, C. J. LSD, marihuana and the law. B.C. Med J.,;1967, 9, 2-74285.
195. Schwarz, C. J. The complications of LSD: A review_ of the literature. Paper read at the annual meeting of the North Pacific Society of Psychiatry and Neurology, Vancouver, B.C., April 6-8, 1967.
196. Schwarz, C. J. Towards a medical understanding of, marihuana. Papen read at the Western Regional Meeting of the Canadian Psychiatric Association, Vancouver, B.C., January 23, 1969.
197. Seneca. Epistle LXXXIII, On drunkenness. Quart. J. Stud Alcoh., 1942, 3, 320-327.
198. Sharpless, S. K. Hypnotics and sedatives. In L. S. Goodman & A. Gilman, The pharmacological basis of therapeutics. (3rd ed.) New York: MacMillan, 1965.
199. Shulgin, O. T. Recent developments in cannabis chemistry. J.-Psychedel.Drugs. 1968, 2, 15-29.    /
200 Siegler, M.; & Osmond, H. Models of drug addiction. Int. J Addiet.,1968,
201. Siler, J. F., ,Sheep, W. L., Bates, L. B., Clark, G. F., Cook, G. W., & Smith,W. A. Marijuana smoking in Panama. Mil. Surg., 1933, 73, 269-280.
202. Simmons, J. L. (Ed.) Marihuana: Myths and realities. North Hollywood, 'Cal.: Brandon House, 1967.
203 Smart, R. G. LSD: Problems and promise. Can. Ment. Health, 1968, 16, Suppl. No. 57.
204 Smart, R. G., and Bateman, K. Unfavorable reactions to LSD. Canad. :• Med. Ass. J, 1967, 97, 1214-.
205 Smart, R. G„ Storm, T., Baker, E. F. W., & Solursh, L. Lysergic acid diethylamide (LSD) in the treatment of alcoholism. Toronto: University of ;", Toronto Press, 1967.
206. Smith, D. E. Acute and chronic toxicity of marijuana. J. Psychedelic Drugs,  1968, 2, 37-47.    }
207. Smith, D. E. Physical vs. psychological dependence and tolerance in high-dose methamphetamine abuse. Clin. Toxicol., 1969, 2, 99-103.    1
208. Smith, H. Do drugs have religious import? J. Phil., 1964, 61 (18). Ro- printed in D. Soloman (Ed.), op. cit., 1964.    Il
209. Smith, Kline & French Laboratories.- Drug abuse: Escape to nowhere. Philadelphia: 1967.D. (Ed) LSD: The consciousness-expanding    1
210. Solomon,    pandtng drug. New York: '1G. P. Putman, 1964.
211. Solomon, D. (Ed.) The marihuana papers. New York: New American Library, 1966.
212. Solursh, L. P., & Solursh, M. J. llluelnogenic drugs: Their effects on criminal :1 responsibility. Toronto: Canadian Mental Health Association, 1969.
213. Solursh, L. P. Some medical observations on the use and abuse of illusinogenic drugs. In L. Rutman (Ed.), Proceedings of University of Winnipeg;; Conference. Winnipeg: University of Winnipeg, 1969.
214. Stafford, P. G., & Golightly, B. H. LSD: The problem-solving psychedelic. 1
215. Stevenson, G. H. Drug addiction in British Columbia. Vancouver: Uni varsity of British Columbia, 1956.
216. Stewart, C. P., & Stooman A. (Eds.) Toxicology: Mechanisms and analytical-1 methods. Vol. 1. The toxicologist and his work. New York: Academic Press, 1960.
217. Suchman, E. A. The "Hang-Loose" ethic and the spirit of drug use. J. Health Soc. Behay., 1968, 9, 146-155.
218. Talbott, J. A., & Teague, J. W. Marihuana psychosis. J.A.M.A., 1969, 1 210, 299-302.
219. Tart, C. T. Marijuana intoxication: Common experimental effects. Paper 0 presented at a meeting of the Faculty of the Langley-Porter Neuropsychi- :â atric Institute, San Francisco, California, January, 1970. 4
220. Task Force report: Narcotics and drug abuse. Annotations and consultant, papers. The President's Commission on Law Enforcement and Administra-4 tion of Justice. Washington, D.C.: U.S. Government Printing Office, 1967
221. Task Force report : Narcotics, marijuana and dangerous drugs. Findings and recommendations. Special Presidential task force. Washington, D.C.: U.S.' Government Printing Office, 1969.    -
222. Taylor, G. C. An analysis of the Problems presented in the use of LSD. Bull. Nam., 1967, 19, 7-13.
223. Taylor, N. Narcotics: Nature's dangerous gifts. (Rev. ed.) New York: Dell, 1966.    -
224. Thompson, T., & Schuster, C. R. Behavioral pharmacology. Englewood, Cliffs, N.J.: Prentice-Hall, 1968.
225. Tijo, J. H., Pahnke, W. N., & Kirland, A. A. LSD and chromosomes. J.A.M.A., 1969, 210, 849-856.
226. UCLA Interdepartmental Conference. Drug dependency: Investigations of stimulants and depressants. Moderator: Anthony Kales. Ann Intern... Med., 1969, 70, 591-614.
227. Uhr, L. (Ed.) Drugs and behaviour. New York: Wiley, 1960.
228. Unger, S. M. Mescaline, LSD, Psilocybin, and personality ' change. Psychiatry: Journal for the study of Interpersonal Processes, 1963, 26 (2). Also reprinted in D. Solomon, op. cit., 1964.
229. Ungerleider, J. T., Fisher, D., & Fuller, M. The danger of LSD: Analysis of seven months' experience in a university hospital's psychiatric service. J.A.M.A.,1966, 197, 389-392.
230. Ungerleider, J. T., Fisher, D. D., Goldsmith, S. R., Fuller, M. & Forgy, E. A statistical survey of adverse reactions to LSD in Los Angeles county. Amer. J. Psychiat., 1968, 125, 352-357.
231. Unsigned. Cannabis—yet another teratogen. Brit. Med. J., 1969, I, 797-.
232. Unwin, J. R. Illicit drug use among Canadian youth. Canad. Med. Ass. J., 1968, 98, 402-.407, 449-454.
233, Unwin, J. R. Non-medical use of drugs with particular reference to youth. Canad. Med. Ass. J., 1969, 101, 72-88.
234. Victor, M., & Adams, R. D. The effect of alcohol on.the nervous system. Res. Publ. Ass. Nerv. Ment. Dis., 1953, 32, 526-573.
235. Waller, C. W. The national marihuana program. First annual report. Bethesda, Maryland: U.S. National Institute of Mental Health, 1969.
236. Walton, R. P. Marihuana: America's new drug problem. Philadelphia: Lippincott, 1938.
237. Wasson, R. G. Fly Agaric and man. In D. H. Efron (Ed.), Ethnopharmacologic search for psychoactive drugs-1967. Washington, D.C.: U.S. Government Printing Office, 1967.
238. Weil, A. T. Cannabis. Science J., 1969, SA, 36-42.
239. Weil, A. T., & Zinberg, N. E. Acute effects of marihuana on s Nature, 1969, 222 (3 May), 434-437.
240. Weil, A. T., Zinberg, N. E., & Nelsen, J. M. Clinical and psychological effects of marihuana in man. Science, 1968, 162, 1234-1242.
241. Whitaker, R. Drugs and the law. Toronto: Methuen, 1969.
242. White House Conference on Narcotic and Drug Abuse. Proceedings. Washington, D.C. Sept. 27-28, 1962, 279-290.
243. Wilder, A. Relationship between clinical effects of barbiturates and their neurophysiological mechanisms of action, Fed. Proc., 1952, 11, 647-652.
244. Wikler, A. The relation of psychiatry to pharmacology. Baltimore: Williams. & Wilkins, 1957.
245. Williams, E. G., Himmelsbach, C. K., Wikler, A., Ruble, D. C., & Lloyd, B. J. Studies on marihuana and pyrahexyl compound. Pub. Health Rep., 1946, 61, 1059-1085.
246 Williams HR Treatment of narcotic addicts with some observations on other drug dependencies B.C. Med. J., 1969, 11,11-13.
247 Wolfe, ,T. The electric kool-dd acid test. New York: Farrar, Straus Giroux, 1968.
'248. Wolff, P. O. Marihuana in Latin America: The threat that it constitutes. - Washington, D.C.: Linacre Press, 1949.
249. Wolstenholme, G. E. W., & Knight, J. (Eds.) Hashish: Its chemistry and pharmacology. Boston: Little, Brown & Co., 1965.
250..Yolks, S. F. Statement for the National Institute of Mental Health, before.
the Subcommittee on Public Health and Welfare of the Interstate Foreign Commerce Committee on House Rule 11701 & House Rule.'.. 13743. February, 1970.
251. Zinberg, N. E., & Weil, A. T. The effects of marijuana on human The New York Times Magazine, May 11, 1969.
252. Zunin, L. M. Marijuana: The drug and the problem. Milit. Med., 1969x' 134, 104-110.